Metformin and Weight Loss in Obese Women with Polycystic Ovary Syndrome: Comparison of Doses

Abstract

Weight loss is a feature of protracted metformin therapy in obese women with PCOS, with greater weight reduction potentially achievable with higher doses. Additional studies are required to determine whether other aspects of the disorder may benefit from the higher dose of metformin.